Voyager Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.About VYGR
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.
CEOAlfred W. Sandrock
CEOAlfred W. Sandrock
Employees172
Employees172
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2013
Founded2013
Employees172
Employees172
VYGR Key Statistics
Market cap198.86M
Market cap198.86M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume463.55K
Average volume463.55K
High today$3.65
High today$3.65
Low today$3.30
Low today$3.30
Open price$3.34
Open price$3.34
Volume738.18K
Volume738.18K
52 Week high$8.28
52 Week high$8.28
52 Week low$2.65
52 Week low$2.65
VYGR News
TipRanks 10h
Voyager Therapeutics Joins Citi’s Biopharma Conference 2025Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own VYGR. This list is generated using Robinhood data, and it’s not a recommendation.